comunicacio

The first Innovation Conference on the Diagnosis and Treatment of Lung Cancer Patients at Bellvitge Campus takes place

During the day there will be a series of talks organised into three thematic blocks: diagnosis and extension studies, treatment of early disease and treatment of advanced cancer.

The first Innovation Conference on the Diagnosis and Treatment of Lung Cancer Patients at Bellvitge Campus takes place Read More »

Researchers identify an immunomodulatory drug as a potential treatment for Parkinson’s disease

Astrocytes in the brains of Parkinson’s patients overexpress the inflammatory cytokine IL-6, which induces the death of dopaminergic neurons. The results have been obtained thanks to obtaining induced pluripotent stem cells from Parkinson’s patients.

Researchers identify an immunomodulatory drug as a potential treatment for Parkinson’s disease Read More »

An anticancer drug opens a new path for the treatment of Parkinson’s

The metabolic product of an anticancer drug demonstrates potential activity in neurons derived from Parkinson’s patients and a synergistic action, together with the original drug, in prostate cancer cells.

An anticancer drug opens a new path for the treatment of Parkinson’s Read More »

IDIBELL’s scientific community will once again claim the role of women and girls in science

The event will take place at the Barradas Auditorium in L’Hospitalet de Llobregat on Thursday, February 8, at 7 p.m. In its 7th edition, the sLHam will once again be starred by six scientists from IDIBELL and two sLHamers from the Bellvitge Institute: a student and a science teacher.

IDIBELL’s scientific community will once again claim the role of women and girls in science Read More »

Scroll to Top